As Medical Liaison to the Center for Telemedicine & Telehealth, Dr. Doolittle consults for one of the most active telemedicine programs in the United States and has been actively involved in the establishment of telemedicine clinics for a variety of disciplines. As a telehealth physician, Dr. Doolittle has conducted over 600 telemedical visits evaluating and managing patients with a wide variety of hematologic and oncologic disorders. Dr. Doolittle has been instrumental in the expansion of the Kansas Telemedicine Project through the development and establishment of additional services including tumor boards, patient education and support groups, and continuing educational events for nurses and physicians. Working as a hospice medical director, he launched one of the first telehospice projects in the country, utilizing home-based telemedicine units to improve care for patients at the end-of-life. Dr. Doolittle is principle investigator for several grants funded through the Technologies Opportunities Program of the Department of Commerce and the Office for the Advancement of Telehealth. He has authored numerous publications concerning telemedicine delivery, teleoncology, telehospice, cost tracking, and patient acceptance.
Dr. Doolittle is Associate Professor of Clinical Oncology at
the University of Kansas Medical Center. He is certified by the
American Board of Internal Medicine with hematology and oncology
subspecialty boards. He has also earned certification by the
American Board of Hospice and Palliative Medicine.
